|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01873 VIVA BIOTECH
Nominal 
1.335 -0.030 (-2.198%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 1,006,519 | 20.994% | 831,874 | 981,824 | 1,142,184 | 1,108,747 |
| Cost of Sales | (664,789) | 34.997% | (492,447) | (642,679) | (736,216) | (763,775) |
| Gross Profit | 341,730 | 0.678% | 339,427 | 339,145 | 405,968 | 344,972 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 30,237 | -42.946% | 52,997 | 59,740 | 13,662 | (5,051) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (297) | -28.947% | (418) | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 109,598 | -36.167% | 171,695 | 185,516 | 36,752 | (63,474) | |
| Taxation | (8,719) | -62.187% | (23,058) | (41,279) | (23,093) | (21,746) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (20,802) | -22.473% | (26,832) | (27,429) | (12,646) | (5,981) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 80,077 | -34.258% | 121,805 | 116,808 | 1,013 | (91,201) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 6,155 | -32.251% | 9,085 | 22,346 | 74,640 | 78,186 |
| Depreciation & Amortisation | 100,417 | -6.819% | 107,766 | 101,601 | 105,768 | 87,254 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 4.000 | -33.333% | 6.000 | 5.000 | 0.100 | -5.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 1.883 | -- | 1.829 | 1.753 | 1.665 | 1.775 |
| Remarks: | Real time quote last updated: 04/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 80,077 |
| %Change | -34.258% |
| EPS / (LPS) | RMB 0.040 |
| NBV Per Share (¥) | RMB 1.883 |